Top compounds associated with response to EIF2D


Feature Type Standardized
Nominal ANOVA
mRNA bendamustine CTRPv2 pan-cancer AAC -0.03 0.5
mRNA GSK429286A GDSC1000 pan-cancer AAC -0.025 0.5
mRNA barasertib CTRPv2 pan-cancer AAC -0.025 0.5
mRNA Oxaliplatin CTRPv2 pan-cancer AAC 0.026 0.5
mRNA DBeQ CTRPv2 pan-cancer AAC -0.028 0.5
mRNA BRD8958 CTRPv2 pan-cancer AAC -0.03 0.5
mRNA PLX4720 GDSC1000 pan-cancer AAC 0.023 0.5
mRNA sotrastaurin CTRPv2 pan-cancer AAC -0.03 0.5
mRNA RDEA119 FIMM pan-cancer AAC 0.12 0.5
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.023 0.5
Download CSV